HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth S Koblan Selected Research

Antidepressive Agents (Antidepressants)

1/2021Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth S Koblan Research Topics

Disease

23Schizophrenia (Dementia Praecox)
03/2024 - 11/2010
7Migraine Disorders (Migraine)
11/2009 - 01/2002
6Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 07/2009
5Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 11/2015
4Body Weight (Weight, Body)
01/2024 - 06/2009
4Parkinson Disease (Parkinson's Disease)
08/2023 - 10/2008
4Psychotic Disorders (Schizoaffective Disorder)
08/2023 - 01/2019
3Bipolar Disorder (Manic Depressive Psychosis)
12/2022 - 01/2021
3Pain (Aches)
11/2010 - 02/2003
3Hyperalgesia
07/2007 - 02/2003
2Binge-Eating Disorder (Binge Eating Disorder)
04/2024 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2024 - 01/2024
2Weight Gain
01/2024 - 06/2009
2Obesity
01/2024 - 06/2009
2Cognitive Dysfunction
08/2023 - 08/2023
2Sleepiness
01/2023 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
12/2022 - 11/2006
2Major Depressive Disorder (Major Depressive Disorders)
10/2016 - 08/2013
2Neuralgia (Stump Neuralgia)
07/2011 - 08/2002
1Prediabetic State (Prediabetes)
03/2024
1Nausea
08/2023
1Hallucinations (Hallucination)
08/2023
1Dizziness (Lightheadedness)
08/2023
1Disorders of Excessive Somnolence (Hypersomnia)
08/2023
1Confusion (Bewilderment)
08/2023
1Cataplexy
01/2023
1Narcolepsy
01/2023
1Autistic Disorder (Autism)
12/2022
1Substance-Related Disorders (Drug Abuse)
01/2022
1Mood Disorders (Mood Disorder)
01/2021
1Headache (Headaches)
01/2020
1Bulimia (Binge Eating)
01/2020
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2020
1Neurobehavioral Manifestations
10/2019
1Epilepsy (Aura)
11/2010
1Nervous System Diseases (Neurological Disorders)
11/2010
1Hyperemia
11/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2009
1Myocardial Infarction
11/2009
1Atrial Fibrillation
01/2009
1Cardiac Arrhythmias (Arrythmia)
01/2009
1Absence Epilepsy (Childhood Absence Epilepsy)
10/2008
1Seizures (Absence Seizure)
10/2008
1Essential Tremor (Essential Tremors)
10/2008

Drug/Important Bio-Agent (IBA)

18SEP-363856IBA
03/2024 - 10/2019
14Trace amine-associated receptor 1IBA
03/2024 - 01/2020
9Antipsychotic Agents (Antipsychotics)IBA
03/2024 - 01/2018
8Serotonin (5 Hydroxytryptamine)IBA
08/2023 - 11/2009
74- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA
04/2024 - 11/2015
75-HT1A Serotonin ReceptorIBA
08/2023 - 10/2016
6Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
02/2008 - 01/2002
5Calcitonin Gene-Related PeptideIBA
02/2008 - 01/2002
4Serotonin 5-HT1 Receptor AgonistsIBA
08/2023 - 10/2021
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2023 - 10/2019
3CarrageenanIBA
07/2007 - 02/2003
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
04/2024 - 08/2013
2Triglycerides (Triacylglycerol)IBA
01/2024 - 12/2021
2Lurasidone HydrochlorideFDA Link
10/2023 - 01/2018
2Dopamine (Intropin)FDA LinkGeneric
08/2023 - 02/2016
2Amisulpride (Solian)IBA
01/2022 - 01/2021
2T-Type Calcium Channels (T-Type Calcium Channel)IBA
11/2010 - 06/2009
2olcegepantIBA
02/2008 - 01/2002
2piperidineIBA
02/2008 - 11/2007
14- (3- fluoro- 2- methylphenyl)- 4,5- dihydrooxazol- 2- ylamineIBA
01/2024
1RO5166017IBA
01/2024
1Olanzapine (Zyprexa)FDA Link
01/2024
1CorticosteroneIBA
01/2024
1Glutamic Acid (Glutamate)FDA Link
12/2023
1Risperidone (Risperdal Consta)FDA LinkGeneric
12/2022
1ProlactinIBA
12/2021
1CholesterolIBA
12/2021
1Capsules (Microcapsules)IBA
10/2021
1TabletsIBA
10/2021
1Dopamine Receptors (Dopamine Receptor)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Chlorpromazine (Thorazine)FDA Link
10/2019
1Phencyclidine (Angel Dust)IBA
10/2019
13,4-dihydroxyphenylglycolIBA
02/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2016
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
08/2013
1Orexin Receptor AntagonistsIBA
01/2010
1Tryptamines (Triptans)IBA
11/2009
1Sumatriptan (Imigran)FDA LinkGeneric
11/2009
1OrexinsIBA
07/2009
12- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA
06/2009
1triphenylphosphine oxideIBA
01/2009
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2009
1compound 30IBA
10/2008
1telcagepantIBA
02/2008
1NeuropeptidesIBA
02/2008
1Amyloid beta-PeptidesIBA
11/2006
1Proteins (Proteins, Gene)FDA Link
11/2006
1Peptides (Polypeptides)IBA
11/2006
1Amyloid (Amyloid Fibrils)IBA
11/2006
1BenzodiazepinesIBA
10/2006
1PiperidinesIBA
10/2006

Therapy/Procedure

3Therapeutics
01/2022 - 02/2008
2Ligation
07/2011 - 08/2002
1Glycemic Control
01/2024
1Oral Administration
07/2011